BiotechTube

Treatment for Fibromyalgia

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fibromyalgia

Conditions

Fibromyalgia

Trial Timeline

Jun 1, 2008 → Apr 1, 2011

NCT ID
NCT00725101

About Treatment for Fibromyalgia

Treatment for Fibromyalgia is a pre-clinical stage product being developed by Eli Lilly for Fibromyalgia. The current trial status is completed. This product is registered under clinical trial identifier NCT00725101. Target conditions include Fibromyalgia.

What happened to similar drugs?

11 of 20 similar drugs in Fibromyalgia were approved

Approved (11) Terminated (3) Active (9)
✅zonisamideEisaiApproved
✅DuloxetineEli LillyApproved
✅duloxetine hydrochloride + placeboEli LillyApproved
✅Duloxetine + PlaceboEli LillyApproved
✅Eszopiclone + placeboSumitomo PharmaApproved
✅QuetiapineAstraZenecaApproved
✅amitriptyline + quetiapineAstraZenecaApproved

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00725101Pre-clinicalCompleted

Competing Products

20 competing products in Fibromyalgia

See all competitors
ProductCompanyStageHype Score
DS-5565 + Pregabalin + Placebo tablet + Placebo capsuleDaiichi SankyoPhase 3
40
DS-5565Daiichi SankyoPhase 3
40
DS-5565 + PlaceboDaiichi SankyoPhase 3
40
DS-5565 + Pregabalin + Placebo tablet + Placebo capsuleDaiichi SankyoPhase 3
40
DS-5565 + Pregabalin + Placebo tablet + Placebo capsuleDaiichi SankyoPhase 3
40
ASP8062 + PlaceboAstellas PharmaPhase 2
35
ASP0819 + PlaceboAstellas PharmaPhase 2
35
DuloxetineShionogiPhase 3
40
Duloxetine 60 mg + PlaceboShionogiPhase 3
40
zonisamideEisaiApproved
35
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
42
DuloxetineEli LillyApproved
35
duloxetine hydrochloride + placeboEli LillyApproved
43
duloxetineEli LillyPhase 3
40
Duloxetine + placeboEli LillyPhase 3
40
Duloxetine + PlaceboEli LillyPhase 3
40
Duloxetine + PlaceboEli LillyApproved
43
Duloxetine + PlaceboEli LillyPhase 3
40
duloxetine + placeboEli LillyPhase 3
40
Eszopiclone + placeboSumitomo PharmaApproved
43